Lung Cancer
Conference Coverage
‘Groundbreaking’ Trial Shows Survival Benefits in Lung Cancer
Presentation on treatment for limited stage small cell lung cancer draws rounds of applause at the annual meeting of the American Society of...
Feature
The ASCO Annual Meeting Starts This Week
More than 7000 abstracts were submitted for this year’s meeting a new record — and over 5000 were selected for presentation.
From the Journals
ASTRO Releases New EBRT Guideline for Symptomatic Bone Mets
Recommendations concerning pain management and quality of life are part of the guidance.
Feature
Obesity and Cancer: Untangling a Complex Web
Is gaining weight later in life better or worse for cancer risk than being overweight or obese from a young age?
Latest News
LDCT Lung Cancer Screening Finds Undiagnosed Pulmonary Comorbidities in High-Risk Population
Though not backed by guidelines, use of low-dose CT may help find undiagnosed COPD or other pulmonary disease in those at high-risk.
Feature
Does More Systemic Treatment for Advanced Cancer Improve Survival?
Researchers evaluate whether patients treated in practices with higher rates of systemic therapy for very advanced disease have longer survival....
Feature
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
Cancer biomarkers in urine are not nearly as widely studied as those in the blood, but a new wave of urine tests suggests research is gaining pace...
Latest News
‘Big Breakthrough’: New Low-Field MRI Is Safer and Easier
New study describes ultra low–field MRI to allow for whole-body scanning.
News from the FDA/CDC
FDA Approves Tarlatamab for Extensive-Stage Small Cell Lung Cancer
Approval was based on data from 99 patients in the DeLLphi-301 trial with relapsed/refractory extensive-stage SCLC who had progressed after...
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
Conference Coverage
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies
Survey respondents classify and grade morbilliform, psoriasiform, and papulopustular rashes based on a review of photographs and text descriptions...